Spanish consensus document for the use of cyclosporine for microemulsion (Sandimmun Neoral®) in dermatology;Documento de consenso Espanol para el uso de ciclosporina para microemulsion (Sandimmun Neoral®) en dermatologia

Actas Dermo-Sifiliograficas

Volumn 91, Issue 7-8, 2000, Pages 357-364

  Ferrandiz, C ^a   Hernanz, J M ^a   Puig, L ^a   Vanaclocha, F ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Atopic dermatitis; Consensus; Cyclosporine; Psoriasis; Short courses

Indexed keywords

CYCLOSPORIN A;

ATOPIC DERMATITIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; HYPERTRICHOSIS; MICROEMULSION; NAUSEA; ORGANIZATION; PARESTHESIA; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; SPAIN; TREATMENT INDICATION;

EID: 0041727503     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Cyclosporine as maintenance therapy in patients with severe psoriasis
2. Neoral® in the treatment of psoriasis: Consensus treatment guidelines
3. Treatment of psoriasis with intermittent short-course cyclosporin (Neoral). A multicentre study
4. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis
5. Cyclosporine consensus conference: With emphasis on the treatment of psoriasis
6. Intermittent short courses of cyclosporine (Neoral®) for psoriasis unresponsive to topical therapy: A 1-year multicentre, randomized study
7. Antipruritic effect of oral cyclosporin A in atopic dermatitis
8. Cyclosporin A in atopic dermatitis: Therapeutic response is dissociated from effects on allergic reactions
9. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
10. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial
11. Cyclosporin in atopic dermatitis: Time to relapse and effect of intermittent therapy
12. Cyclosporine in severe childhood atopic dermatitis a multicenter study
13. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: A comparison of two dosage regimens
14. Treatment of severe atopic dermatitis in childhood with cyclosporin
15. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
16. The efficacy, tolerability and safety of a new oral formulation of Sandimmun-Sandimmun Neoral in severe refractory atopic dermatitis
17. Long-term follow-up of eczema patients treated with cyclosporine
18. Cyclosporin in atopic dermatitis: Review of the literature and outline of a Belgian consensus
19. Cyclosporine in the treatment of dermatologic disease: An update
20. Treatment of pyoderma gangrenosum with cyclosporine
21. Would cyclosporine A be benefitial to mitigate drug-induced toxic epidermal necrolysis?
22. Consensus conference on cyclosporin A for psoriasis
23. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
24. Renal function and blood pressure in psoriatic patients treated with cyclosporine A
25. Cyclosporine-induced hipertension. Incidence, pathogenesis and management
26. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporin
27. Long-term low-dose cyclosporin therapy for severe psoriasis: Effects on renal function and structure
28. Renal biopsy findings in long-term cyclosporin treatment of psoriasis
29. Renal function after 10 years' treatment with cyclosporin for psoriasis
30. Pregnancy outcomes in female renal transplant recipients